Kelsey Todd P. sold $359K of PLXS
Kelsey Todd P. (President & CEO) sold 1,500 shares of PLEXUS CORP (PLXS) at an average of $239.16 ($238.47–$239.92, $0.36M total) across 2 trades on 2026-10-21 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and pre‑arranged, likely resulting in limited market reaction.
Market read
Primary source filing; low‑impact insider sell.
What to watch
Holding size remains sizable (62,888 shares) and may limit further selling pressure.
Background
SEC Form 4 filing discloses a recent insider transaction by Plexus Corp's CEO.
Ticker impact
Form 4 filing shows CEO sold $359K of shares via a 10b5‑1 plan.
potential slight downward pressure as the market prices the insider sell.
The sale is small relative to float and disclosed via a pre‑arranged plan, limiting surprise impact.
Market effects
minimal impact on the medical‑device sector.
none
none
Counterpoint
The sale could be routine and not indicative of future weakness.
Key entities
- companyPlexus Corp
Medical device manufacturer listed on Nasdaq under PLXS.
- personKelsey Todd P.
President & CEO of Plexus Corp who sold shares.

